Rating24 Aug 2026, 09:00 pm
AstraZeneca India Receives ESG Rating of 57 from CRISIL
AI Summary
AstraZeneca Pharma India Ltd has received an Environmental, Social, and Governance (ESG) rating of 57 from CRISIL ESG Ratings & Analytics Limited. The rating was assigned based on publicly available information, and the company has not engaged CRISIL ESG Ratings for this assessment. CRISIL independently prepared the reporting. This independent rating provides an external perspective on the company's ESG performance.
Key Highlights
- CRISIL ESG Ratings assigned an ESG rating of 57 to AstraZeneca India.
- The rating is based on publicly available information.
- AstraZeneca India did not engage CRISIL for this rating.
- CRISIL independently prepared the ESG assessment report.
Price Impact
More from ASTRAZEN